BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//American Liver Foundation - ECPv6.13.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://liverfoundation.org
X-WR-CALDESC:Events for American Liver Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240301T000000
DTEND;TZID=America/New_York:20250329T235959
DTSTAMP:20260420T234748
CREATED:20240805T211801Z
LAST-MODIFIED:20250327T163642Z
UID:10001298-1709251200-1743292799@liverfoundation.org
SUMMARY:Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma (GEA)
DESCRIPTION:We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to better understand established and emerging data related to HER2-targeted therapies in GEA. This on-demand course is available for continuing education credit until 3/29/25. \nUpon completion of this activity\, participants will: \n\nHave increased knowledge regarding the\n\nBiological rationale for using bispecific antibodies to target HER2 in GEA\n\n\nHave greater competence related to\n\nSelecting the most appropriate anti-HER2 therapy for a patient with HER2-positive GEA\nManaging adverse events associated with anti-HER2 therapies for patients with HER2-positive GEA\n\n\nDemonstrate greater confidence in their ability to\n\nCollaborate with the patient when developing a treatment plan for their HER2-positive GEA\n\n\n\nLearn more and register for this course: https://liver.fyi/HER2GEA \n 
URL:https://liver.fyi/HER2GEA#new_tab
LOCATION:On-Demand
CATEGORIES:Programs
ATTACH;FMTTYPE=image/png:https://liverfoundation.org/wp-content/uploads/2024/08/Fact-Sheet-What-Does-Your-Liver-Do.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240610T000000
DTEND;TZID=America/New_York:20240930T235959
DTSTAMP:20260420T234748
CREATED:20240611T153023Z
LAST-MODIFIED:20240611T153023Z
UID:10001054-1717977600-1727740799@liverfoundation.org
SUMMARY:Updates on Hepatitis B and C for Patients
DESCRIPTION:
URL:https://liverfoundation.org/resource-center/videos/updates-on-hepatitis-b-and-c-for-patients/
LOCATION:On-Demand
CATEGORIES:Programs
ATTACH;FMTTYPE=image/png:https://liverfoundation.org/wp-content/uploads/2024/06/Updates-on-Hepatitis-B-and-C-for-patients.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20240929T000000
DTEND;TZID=Europe/Berlin:20240929T235959
DTSTAMP:20260420T234748
CREATED:20230707T162558Z
LAST-MODIFIED:20241029T164506Z
UID:10000459-1727568000-1727654399@liverfoundation.org
SUMMARY:BMW Berlin Marathon
DESCRIPTION:
URL:https://liverlifechallenge.org/berlin/#new_tab
LOCATION:Berlin\, Germany
CATEGORIES:Events
ATTACH;FMTTYPE=image/jpeg:https://liverfoundation.org/wp-content/uploads/2023/07/Berlin.jpeg
END:VEVENT
END:VCALENDAR